This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: John Fred Eaddy, III: Innovator in Selective Estrogen Receptor Modulation
Introduction
John Fred Eaddy, III is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective estrogen receptor modulators. His innovative work has implications for various therapeutic applications.
Latest Patents
Eaddy holds a patent for "Triphenylethylene compounds as selective estrogen receptor modulators." This patent describes compounds of formula (I) that have a variety of therapeutic uses, especially novel prodrugs that are particularly useful for delivering a parent compound for selective estrogen receptor modulation. His work in this area showcases his commitment to advancing medical science.
Career Highlights
John Fred Eaddy, III is associated with SmithKline Beecham Corporation, where he has been instrumental in research and development. His expertise in the field has led to advancements that benefit both the pharmaceutical industry and patients in need of innovative treatments.
Collaborations
Eaddy has collaborated with notable colleagues, including Amarjit Sab Randhawa and Michael Tolar Martin. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
John Fred Eaddy, III is a distinguished inventor whose work in selective estrogen receptor modulation has the potential to impact therapeutic practices significantly. His contributions to the field exemplify the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile